<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="57183">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02126033</url>
  </required_header>
  <id_info>
    <org_study_id>1234</org_study_id>
    <nct_id>NCT02126033</nct_id>
  </id_info>
  <brief_title>Telomeres Parameters in Celiac Disease</brief_title>
  <sponsors>
    <lead_sponsor>
      <agency>Meir Medical Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Meir Medical Center</source>
  <oversight_info>
    <authority>Israel: Ethics Commission</authority>
  </oversight_info>
  <brief_summary>
    <textblock>
      Celiac disease is an autoimmune process that causes destructive changes in the epithel of
      the small bowel and it is also a pre-malignant state (e.g lymphoma). The aim of the study is
      to examine telomere length and other parameters of genetic instability from peripheral blood
      lymphocytes of patients with celiac disease compared with healthy controls.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <primary_completion_date type="Anticipated">December 2015</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Intervention Model: Parallel Assignment, Primary Purpose: Basic Science</study_design>
  <primary_outcome>
    <measure>telomere length</measure>
    <time_frame>at entry, after 6 months of gluten-free diet</time_frame>
    <safety_issue>No</safety_issue>
  </primary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Celiac Disease</condition>
  <arm_group>
    <arm_group_label>celiac disease</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>take blood samples</intervention_name>
    <arm_group_label>celiac disease</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  patients with celiac disease

        Exclusion Criteria:

          -  known malignancy

          -  cannot sign informed consent

          -  under age 18
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <verification_date>April 2014</verification_date>
  <lastchanged_date>April 27, 2014</lastchanged_date>
  <firstreceived_date>April 27, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Meir Medical Center</investigator_affiliation>
    <investigator_full_name>ido laish</investigator_full_name>
    <investigator_title>physician in gastroenterlogy institute</investigator_title>
  </responsible_party>
  <keyword>celiac</keyword>
  <keyword>telomere</keyword>
  <keyword>telomerase</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Celiac Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
